Lipid nanoparticles emerge as leading siRNA carriers for liver cancer therapy
A new review outlines how lipid-based nanomedicines could deliver pathway-specific siRNA to treat hepatocellular carcinoma, highlighting delivery design, preclinical candidates ...
